(Reuters) - Aveo Pharmaceuticals Inc and Astellas Pharma Inc have not demonstrated that the benefits of their experimental kidney cancer drug tivozanib outweighs the risk, an advisory panel to the U.S. Food and Drug Administration said on Thursday. Full story
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday said it would allow the Plan B One-Step contraceptive to be sold without a prescription to girls as young as 15 years of age. Full story
(Reuters) - Generic drugmaker Mylan Inc said on Tuesday it has hired Deborah Autor, deputy commissioner for global regulatory operations and policy at the U.S. Food and Drug Administration, to help oversee its global regulatory strategy. Full story
(Reuters) - The U.S. Food and Drug Administration has developed a hand-held device capable of identifying counterfeit or substandard malaria drugs and has signed a letter of intent with Corning Inc to manufacture the product. Full story
LONDON (Reuters) - BTG's Varisolve treatment for varicose veins has been accepted for review by the U.S. Food and Drug Administration, putting it on track for potential approval and launch during the first half of 2014. Full story
(Reuters) - The U.S. Food and Drug Administration said on Wednesday it is requesting a budget of $4.7 billion in fiscal 2014, including $295.8 million to implement new food safety regulations. Full story
A Plan B One-Step emergency contraceptive box is seen in New York, April 5, 2013. A federal judge on Friday ordered the U.S. Food and Drug Administration to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age. REUTERS/Shannon Stapleton
The headquarters of the U.S. Food and Drug Administration is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed
Staff Scientist Ji Guo inspects test tubes containing dyes in a laboratory at the U.S. Food and Drug Administration in Silver Spring, Maryland in this file photo from August 14, 2012. Picture taken August 14, 2012. The Food and Drug Administration announced a reduction of $133 million in non-user
Staff Scientist Ji Guo inspects test tubes containing dyes in a laboratory at the U.S. Food and Drug Administration in Silver Spring, Maryland in this August 14, 2012 file photo. Research and the fight against infectious diseases could be on the list of cutbacks as the White House warns of possibl
